Skip to main content
Clinical Trials/CTRI/2015/05/005795
CTRI/2015/05/005795
Completed
未知

An observational study to evaluate the pattern of multiple drug resistance pathogens (Extended-Spectrum β-lactamases Producing Strains, Carbapenem Resistant Enterobacteriaceae and Methicillin Resistant Staphylococcus Aureus) seen in hospital acquired pneumonia patients admitted in tertiary care centres across India. - ASPI

Sanofi India Limited0 sites184 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sanofi India Limited
Enrollment
184
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2016
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient is \>\= 18 years of age and \<70 Year.
  • 2\.The patient has been diagnosed as Hospital Acquired Pneumonia (HAP) as per CDC /NHSN Surveillance definition.
  • 3\.Bacteriological culture and sensitivity report showing presence of at least one causative pathogen.
  • 4\.Signed Informed consent obtained prior to any study related procedures.

Exclusion Criteria

  • 1\.Are currently enrolled in, or discontinued within the last 30 days from, a clinical trial involving an investigational product or concurrently enrolled in any other type of medical research.

Outcomes

Primary Outcomes

Not specified

Similar Trials